OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor Necrosis Factor Inhibitor Therapy: A Rare Case Report

REFERENCES

1. 1.↵
   1. Damgaard RB,
   2. Walker JA,
   3. Marco-Casanova P, et al

   . The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell 2016;25;166:1215-30.e20.

   OpenUrl
2. 2.↵
   1. Zhou Q,
   2. Yu X,
   3. Demirkaya E, et al

   . Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U S A 2016;113:10127-32.

   OpenUrlAbstract/FREE Full Text
3. 3.
   1. Nabavi M,
   2. Shahrooei M,
   3. Rokni-Zadeh H, et al

   . Auto-inflammation in a patient with a novel homozygous OTULIN mutation. J Clin Immunol 2019;39:138-41.

   OpenUrlCrossRefPubMed
4. 4.
   1. Damgaard RB,
   2. Elliott PR,
   3. Swatek KN, et al

   . OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death. EMBO Mol Med 2019;11:e9324.

   OpenUrlAbstract/FREE Full Text
5. 5.
   1. Zinngrebe J,
   2. Moepps B,
   3. Monecke T, et al

   . Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS. EMBO Mol Med 2022;14:e14901.

   OpenUrlPubMed
6. 6.↵
   1. Caballero-Oteyza A,
   2. Crisponi L,
   3. Peng XP, et al

   . OTULIN-related conditions: report of a new case and review of the literature using GenIA. Clin Immunol 2024;265:110292.

   OpenUrlPubMed
7. 7.↵
   1. Spaan AN,
   2. Neehus AL,
   3. Laplantine E, et al

   . Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin. Science 2022;376:eabm6380.

   OpenUrlPubMed
8. 8.↵
   1. Davidson S,
   2. Shibata Y,
   3. Collard S, et al

   . Dominant negative OTULIN-related autoinflammatory syndrome. J Exp Med 2024;221:e20222171.

   OpenUrlPubMed
9. 9.↵
   1. Takeda Y,
   2. Ueki M,
   3. Matsuhiro J, et al

   . A de novo dominant-negative variant is associated with OTULIN-related autoinflammatory syndrome. J Exp Med 2024;221:e20231941.

   OpenUrlPubMed
10. 10.↵
    1. Bousfiha A,
    2. Moundir A,
    3. Tangye SG, et al

    . The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol 2022;42:1508-20.

    OpenUrlPubMed